Skip to main content

Table 4 Univariable Cox regression analysis of disease-specific survival for colorectal cancer patients

From: Serum MMP-8 and TIMP-1 predict prognosis in colorectal cancer

 

Hazard ratio

95% CI

P-value

Age, years

  < =65

1.00

  

  > 65

1.44

0.98–2.10

0.062

Gender

 Male

1.00

  

 Female

1.06

0.73–1.54

0.772

Dukes classification

 A

1.00

  

 B

3.33

0.96–11.5

0.057

 C

11.0

3.45–35.3

< 0.001

 D

29.3

9.05–95.1

< 0.001

pT stage

 pT1

1.00

  

 pT2

1.62

0.21–12.8

0.648

 pT3

6.33

0.88–45.5

0.067

 pT4

9.89

1.31–75.0

0.067

pN stage

 pN0

1.00

  

 pN1

3.77

2.33–6.09

< 0.001

 pN2

5.16

3.15–8.50

< 0.001

pM stage

 pM0

1.00

  

 pM1

5.31

3.55–7.93

< 0.001

Grade

 I

1.00

  

 II

1.38

0.60–3.17

0.445

 III

1.07

0.36–3.18

0.906

 IV

2.16

0.78–5.93

0.137

Side

 Right

1.00

  

 Left

1.45

0.92–2.28

0.107

Location

 Colon

1.00

  

 Rectum

1.16

0.79–1.69

0.453

Histologic type

 Adeno

1.00

  

 Mucinous

0.95

0.46–1.95

0.888

MMP-8 concentration

 Low

1.00

  

 High

1.72

1.17–2.52

0.005

MMP-9 concentration

 Low

1.00

  

 High

0.89

0.61–1.31

0.564

TIMP-1 concentration

 Low

1.00

  

 High

1.80

1.23–2.64

0.002

MMP-8/TIMP-1 ratio

 Low

1.00

  

 High

1.48

1.01–2.16

0.045

MMP-9/TIMP-1 ratio

 Low

1.00

  

 High

0.65

0.45–0.96

0.027

CRP (mg/l)

  < =30

1.00

  

  > 30

1.75

1.09–2.82

0.021

  1. Abbreviations: MMP matrix metalloproteinase, TIMP-1 tissue inhibitor of metalloproteinases-1, CI confidence interval